MicroRNA‑33a‑5p overexpression sensitizes triple‑negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial‑mesenchymal transition

Xiaoqing Guan(Chinese Academy of Sciences), Ji Wu(Xuzhou Medical College)
Oncology Letters
October 14, 2019
Cited by 32


Related Papers